These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 22371021)

  • 1. Surface epithelialization of the type I Boston keratoprosthesis front plate: immunohistochemical and high-definition optical coherence tomography characterization.
    Kiang L; Rosenblatt MI; Sartaj R; Fernandez AG; Kiss S; Radcliffe NM; D'Amico DJ; Sippel KC
    Graefes Arch Clin Exp Ophthalmol; 2012 Aug; 250(8):1195-9. PubMed ID: 22371021
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Boston type I keratoprosthesis-donor cornea interface evaluated by high-definition spectral-domain anterior segment optical coherence tomography.
    Fernandez AG; Radcliffe NM; Sippel KC; Rosenblatt MI; Sood P; Starr CE; Ciralsky JB; D'Amico DJ; Kiss S
    Clin Ophthalmol; 2012; 6():1355-9. PubMed ID: 22969280
    [TBL] [Abstract][Full Text] [Related]  

  • 3. High-resolution spectral domain anterior segment optical coherence tomography in type 1 Boston keratoprosthesis.
    Shapiro BL; Cortés DE; Chin EK; Li JY; Werner JS; Redenbo E; Mannis MJ
    Cornea; 2013 Jul; 32(7):951-5. PubMed ID: 23591146
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Intra-operative optical coherence tomography in corneal lamellar graft reinforcement for Boston type I keratoprosthesis corneal melt.
    Zeng L; Chen M; Lin L; Zhai J; Chen J; Gu J
    Indian J Ophthalmol; 2023 Jul; 71(7):2892-2896. PubMed ID: 37417141
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Boston type I keratoprosthesis: improving outcomes and expanding indications.
    Aldave AJ; Kamal KM; Vo RC; Yu F
    Ophthalmology; 2009 Apr; 116(4):640-51. PubMed ID: 19243830
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluation of the stability of Boston type I keratoprosthesis-donor cornea interface using anterior segment optical coherence tomography.
    Garcia JP; Ritterband DC; Buxton DF; De la Cruz J
    Cornea; 2010 Sep; 29(9):1031-5. PubMed ID: 20517152
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Boston keratoprosthesis type I in the elderly.
    Homayounfar G; Grassi CM; Al-Moujahed A; Colby KA; Dohlman CH; Chodosh J
    Br J Ophthalmol; 2017 Apr; 101(4):514-518. PubMed ID: 27381593
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Boston keratoprosthesis in the management of corneal limbal stem cell deficiency.
    Sejpal K; Yu F; Aldave AJ
    Cornea; 2011 Nov; 30(11):1187-94. PubMed ID: 21885964
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Boston Type 1 Keratoprosthesis for Gelatinous Drop-Like Corneal Dystrophy.
    Lekhanont K; Jongkhajornpong P; Chuephanich P; Inatomi T; Kinoshita S
    Optom Vis Sci; 2016 Jun; 93(6):640-6. PubMed ID: 26990741
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Anterior segment optical coherence tomography findings in type I Boston keratoprosthesis.
    Silva LD; Santos A; Sousa LB; Allemann N; Oliveira LA
    Arq Bras Oftalmol; 2018; 81(1):42-46. PubMed ID: 29538593
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Boston keratoprosthesis type II: the Massachusetts Eye and Ear Infirmary experience.
    Pujari S; Siddique SS; Dohlman CH; Chodosh J
    Cornea; 2011 Dec; 30(12):1298-303. PubMed ID: 21963861
    [TBL] [Abstract][Full Text] [Related]  

  • 12. International results with the Boston type I keratoprosthesis.
    Aldave AJ; Sangwan VS; Basu S; Basak SK; Hovakimyan A; Gevorgyan O; Kharashi SA; Jindan MA; Tandon R; Mascarenhas J; Malyugin B; Padilla MD; Maskati Q; Agarwala N; Hutauruk J; Sharma M; Yu F
    Ophthalmology; 2012 Aug; 119(8):1530-8. PubMed ID: 22512986
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Longer-term vision outcomes and complications with the Boston type 1 keratoprosthesis at the University of California, Davis.
    Greiner MA; Li JY; Mannis MJ
    Ophthalmology; 2011 Aug; 118(8):1543-50. PubMed ID: 21397948
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The use of precut, γ-irradiated corneal lenticules in Boston type 1 keratoprosthesis implantation.
    Akpek EK; Aldave AJ; Aquavella JV
    Am J Ophthalmol; 2012 Sep; 154(3):495-498.e1. PubMed ID: 22633353
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Epithelial downgrowth after type 1 Boston keratoprosthesis manifesting as tractional retinal detachment and epiretinal membrane.
    Bielory BP; Jacobs D; Alfonso E; Perez VL; Dubovy SR; Berrocal A
    Arch Ophthalmol; 2012 Jan; 130(1):118-20. PubMed ID: 22232484
    [No Abstract]   [Full Text] [Related]  

  • 16. Periprosthetic Tissue Loss in Patients With Idiopathic Vitreous Inflammation After the Boston Keratoprosthesis.
    Grassi CM; Cruzat A; Taniguchi EV; Crnej A; Colby KA; Dohlman CH; Chodosh J
    Cornea; 2015 Nov; 34(11):1378-82. PubMed ID: 26226472
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Long-term outcomes of the MICOF keratoprosthesis surgery.
    Wang L; He X; Wang Q; Wu T; Liu A; Huang Y
    Ocul Surf; 2021 Jul; 21():178-185. PubMed ID: 34118425
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Boston type I keratoprosthesis assisted with intraprosthetic amniotic membrane (AmniotiKPro sandwich technique).
    Navas A; Hernandez-Camarena JC; Serna-Ojeda JC; Ramirez-Miranda A; Graue-Hernández EO
    Acta Ophthalmol; 2015 Feb; 93(1):e87-8. PubMed ID: 24797302
    [No Abstract]   [Full Text] [Related]  

  • 19. Challenges in management of the Boston Keratoprosthesis Type 1.
    Koo EH; Hannush SB
    Curr Opin Ophthalmol; 2021 Jul; 32(4):385-388. PubMed ID: 33973907
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Boston type 1 keratoprosthesis: the university of california davis experience.
    Bradley JC; Hernandez EG; Schwab IR; Mannis MJ
    Cornea; 2009 Apr; 28(3):321-7. PubMed ID: 19387235
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.